Tag: Margaret Ritchie

  • Margaret Ritchie – 2015 Parliamentary Question to the Foreign and Commonwealth Office

    Margaret Ritchie – 2015 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Margaret Ritchie on 2015-10-16.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, what recent representations his Department has made on human rights in China.

    Mr Hugo Swire

    We pay close attention to the human rights situation in China and outline a range of our concerns in the Foreign and Commonwealth Office’s Annual Report on Human Rights and Democracy.

    Bilaterally, we are one of only a few countries to maintain an annual human rights dialogue with China: the most recent dialogue was in Beijing in April. Ministers also consistently raise human rights issues. The Secretary of State for Foreign and Commonwealth Affairs, my right hon. Friend the Member for Runnymede and Weybridge (Mr Hammond) raised the matter of detained lawyers during his visit to China in August. I raised concerns over a proposed draft non-government organisation law with Ambassador Liu Xiaoming in June.

    We also make representations through international mechanisms. In a statement to the Human Rights Council on 21 September, the UK made clear that it remained concerned by reports of the detention of human rights lawyers since 9 July 2015, and urged the Chinese authorities to release these lawyers.

  • Margaret Ritchie – 2015 Parliamentary Question to the Department of Health

    Margaret Ritchie – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Margaret Ritchie on 2015-10-15.

    To ask the Secretary of State for Health, if he will take steps to reduce the waiting times for autism diagnosis; and if he will make a statement.

    Alistair Burt

    The Department has discussed with NHS England the difficulties that people on the autistic spectrum can have in getting an appropriate diagnosis in a timely manner. With support from the Department, NHS England and the Association of Directors of Social Services will undertake a series of visits to clinical commissioning groups to discuss good practice in meeting the National Institute for Health and Care Excellence (NICE) Quality Standard 51 Autism, and those that do not, with the aim of supporting more consistent provision. These NICE guidelines already recommend that there should be a maximum of three months between a referral and a first appointment for a diagnostic assessment for autism. We expect the National Health Service to be working towards meeting the recommendations.

  • Margaret Ritchie – 2015 Parliamentary Question to the Foreign and Commonwealth Office

    Margaret Ritchie – 2015 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Margaret Ritchie on 2015-10-15.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, what assessment he has made of recent progress towards achieving a political solution to the conflict in Syria.

    Mr Tobias Ellwood

    The only way to end the conflict in Syria is through a negotiated settlement to create an inclusive government, which can protect its people from the tyranny of ISIL and other extremists. We support the efforts of UN Special Envoy de Mistura to facilitate this. Russian actions have complicated the situation in Syria, making a political transition less likely. It is clear that Russia is carrying out airstrikes against the moderate opposition, who must be part of a political process. We call on Russia to stop targeting moderate opposition groups and to use its influence with the regime to deliver genuine negotiations on a political transition.

  • Margaret Ritchie – 2015 Parliamentary Question to the Home Office

    Margaret Ritchie – 2015 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Margaret Ritchie on 2015-10-15.

    To ask the Secretary of State for the Home Department, whether the Wilson Doctrine has been consistently applied to the communications of the hon. Member for South Down; and whether that Member has been subject to surveillance.

    Mr John Hayes

    The Government’s position on the Wilson Doctrine was set out by the Prime Minister in a written ministerial statement made on 4 November 2015.

    As the Prime Minister made clear, the Wilson Doctrine has never been an absolute bar to the targeted interception of the communications of Members of Parliament or an exemption from the legal regime governing interception. The Doctrine recognised that there could be instances where interception might be necessary.

    The Prime Minister announced that as matter of policy the PM will be consulted should there ever be a proposal to target any UK Parliamentarian’s communications under a warrant issued by a Secretary of State. This applies to Members of Parliament, members of the House of Lords, the Scottish Parliament, the Northern Ireland Assembly, the Welsh Assembly and UK members of the European Parliament. It applies to all activity authorised by a warrant issued by a Secretary of State: any instance of targeted interception and, electronic surveillance and equipment interference, when undertaken by the Security and Intelligence Agencies. This is in addition to the rigorous safeguards already in the Regulation of Investigatory Powers Act 2000 (RIPA) and the Code of Practice issued under it which set out a series of robust safeguards for any instance of interception.

    It is long standing policy of successive Governments neither to confirm nor deny any specific activity by the Security and Intelligence Agencies. Under the Regulation of Investigatory Powers Act 2000 it is an offence for anyone to identify an individual interception warrant or an individual interception that takes place.

  • Margaret Ritchie – 2015 Parliamentary Question to the Department for Culture, Media and Sport

    Margaret Ritchie – 2015 Parliamentary Question to the Department for Culture, Media and Sport

    The below Parliamentary question was asked by Margaret Ritchie on 2015-10-20.

    To ask the Secretary of State for Culture, Media and Sport, how many applications have been submitted for the voucher broadband scheme; how many such applications came from Northern Ireland; how many of these have been approved; and if he will make available new programmes of broadband funding.

    Mr Edward Vaizey

    The Scheme has been a great success with SMEs right across the UK benefitting from broadband speeds on average 10 times faster than existing connections. My department collects routine data from participating cities, who are responsible for administering broadband connection vouchers in accordance with scheme terms and conditions showing vouchers issued rather than applications made.

    As of 30 September 2015 there were over 40,000 vouchers issued in over 50 cities across the UK, of which around 2,000 were issued in Northern Ireland. All decisions regarding new funding are subject to the Spending Review.

  • Margaret Ritchie – 2015 Parliamentary Question to the Department of Health

    Margaret Ritchie – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Margaret Ritchie on 2015-02-10.

    To ask the Secretary of State for Health, what recent assessment he has made of trends in the rates of people being diagnosed with multiple sclerosis.

    Norman Lamb

    The National Institute for Health and Care Excellence (NICE) guidance Multiple sclerosis: management of multiple sclerosis in primary and secondary care, updated in October 2014, states that around 100,000 people in the United Kingdom have multiple sclerosis (MS). Estimates from studies on annual incidence are more uncertain, and vary between 2,500 and 6,000 newly diagnosed cases each year. About 85 out of 100 people with MS have relapsing–remitting MS (RRMS) where periods of stability (remission) are followed by episodes when there are exacerbations of symptoms (relapses). About 10 to 15 out of 100 people with MS have primary progressive MS where symptoms gradually develop and worsen over time from the start, without ever experiencing relapses and remissions.

    The guidance sets out a range of initial assessments a clinician should make including testing of vision and blood tests before referral to a consultant neurologist who can confirm or exclude a diagnosis of MS, subject to investigation. The guidance makes a range of recommendations on the pharmacological and non-pharmacological management of MS. NICE has recommended a number of drugs for the treatment of MS and is currently appraising Nerventra (laquinimod) for RRMS and ilenya (fingolimod) for primary-progressive MS. In addition over 18,000 patients have benefitted from disease-modifying treatments through the MS risk sharing scheme, established by the Department in 2002.

  • Margaret Ritchie – 2014 Parliamentary Question to the Northern Ireland Office

    Margaret Ritchie – 2014 Parliamentary Question to the Northern Ireland Office

    The below Parliamentary question was asked by Margaret Ritchie on 2014-06-26.

    To ask the Secretary of State for Northern Ireland, what role she will play in the forthcoming talks between party leaders in Northern Ireland.

    Mrs Theresa Villiers

    I welcome the intensification of the party leaders’ talks. The Government will continue to support the parties in their efforts wherever possible. It is essential that early progress is made with every effort to secure an agreement as quickly as possible.

  • Margaret Ritchie – 2014 Parliamentary Question to the Department for Business, Innovation and Skills

    Margaret Ritchie – 2014 Parliamentary Question to the Department for Business, Innovation and Skills

    The below Parliamentary question was asked by Margaret Ritchie on 2015-01-14.

    To ask the Secretary of State for Business, Innovation and Skills, what his policy is on investor-state dispute settlement in the Transatlantic Trade and Investment Partnership.

    Matthew Hancock

    I refer the Hon Member to the answer I gave on 7 November 2014 to question 212541.

  • Margaret Ritchie – 2014 Parliamentary Question to the Foreign and Commonwealth Office

    Margaret Ritchie – 2014 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Margaret Ritchie on 2015-01-14.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, what recent steps he has taken to tackle the persecution of Christians overseas.

    Mr David Lidington

    Freedom of religion or belief is a human rights priority. At all levels of Government, we regularly urge the protection and the right of all, including Christians, to practise their religion or belief without discrimination.

  • Margaret Ritchie – 2015 Parliamentary Question to the Department of Health

    Margaret Ritchie – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Margaret Ritchie on 2015-02-10.

    To ask the Secretary of State for Health, what recent assessment he has made of the effectiveness of the diagnosis and treatment of motor neurone disease.

    Norman Lamb

    Motor neurone disease (MND) is a rare incurable neurodegenerative condition and there are estimated to be up to 5,000 people with MND in the United Kingdom. In its early stages the disease can be difficult to diagnose because the symptoms a patient may present with, such as fatigue, clumsiness and muscle weakness are shared with more common, less serious conditions. No two people with MND will be affected in exactly the same way and there is no one test to diagnose the condition.

    To support general practitioners (GPs) to spot the potential symptoms of MND, the Royal College of General Practitioners (RCGPs) and the MND Association have worked together to produce a ‘Red Flag Tool’ which sets out key signs of MND to help GPs to identify suspected cases and refer them promptly to a neurologist for appropriate investigation. The RCGP and British Medical Journal have also both produced MND e-learning courses which together cover both signs and symptoms as well disease management.

    All services for people with MND should be commissioned as a specialised service in line with NHS England’s neurosciences service specification. This sets out what providers must have in place to deliver high quality specialised neurological care.

    Specialist MND care can include a range of services such as counselling and emotional support, respiratory care, speech and language therapy, physiotherapy, respiratory secretion management, neurorehabilitation, physiotherapy and palliative care. Drugs can be used for symptom management, but riluzole is the only pharmacological drug licensed in the UK to slow the progression of MND.

    Finally, the Department has asked the National Institute for Health and Care Excellence to produce a clinical guideline on MND. Development is currently underway and the guideline is anticipated for publication in February 2016.